Get started
Author

Rupali Sarkar

Observed name: Sarkar, Rupali
ORCID: 0000-0002-3297-3208
Observed ORCID: 0000-0002-3297-3208
OpenAlex ID: A5041498289
Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3′-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer
2024 · Rupali Sarkar, Souradeep Biswas, et al. · Journal of Nanobiotechnology · 75
Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development
2022 · Rituparna Ghosh, Priya Samanta, et al. · Molecules · 67
PDF
Therapeutic Effectiveness of Anticancer Agents Targeting Different Signaling Molecules Involved in Asymmetric Division of Cancer Stem Cell
2023 · Priya Samanta, Arijit Bhowmik, et al. · Stem Cell Reviews and Reports · 13
Natural flavonoid Orientin restricts 5-Fluorouracil induced cancer stem cells mediated angiogenesis by regulating HIF1α and VEGFA in colorectal cancer
2025 · Rituparna Ghosh, Arijit Bhowmik, et al. · Molecular Medicine · 10
Ribosome biogenesis and ribosomal proteins in cancer stem cells: a new therapeutic prospect
2024 · Priya Samanta, Rituparna Ghosh, et al. · Molecular Biology Reports · 7
Current Understanding on Impact of Kirsten Rat Sarcoma Viral Oncogene Mutation on Colorectal Cancer: A Review
2024 · Shampa Pakhira, Priya Samanta, et al. · Journal of Current Oncological Trends · 1
Functionalized Mesoporous Silica Nanoparticles for the Delivery of 3,3'-diindolylmethane to Triple-negative Breast Cancer Cells
2025 · Yashaswi Dutta Gupta, Rupali Sarkar, et al. · Nanoscience &amp Nanotechnology-Asia
Targeting Cancer Stem Cells by Natural Compounds in Combination with Conventional Chemotherapy: An Ideal Strategy for Combating Cancer Recurrence
2024 · Rituparna Ghosh, Souradeep Biswas, et al. · Journal of Current Oncological Trends
Works count: 11
Citation count: 173
H-index: 5
I10-index: 4
Year
Topic
Type